Drug profile · INN
methyldopate hydrochloride
METHYLDOPATE HYDROCHLORIDE
methyldopate hydrochloride (METHYLDOPATE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — methyldopate hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
methyldopate hydrochloride (METHYLDOPATE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methyldopate hydrochloride?
methyldopate hydrochloride (METHYLDOPATE HYDROCHLORIDE) is a adrenergic receptor alpha-2 agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for methyldopate hydrochloride?
METHYLDOPATE HYDROCHLORIDE is a marketed brand name for methyldopate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methyldopate hydrochloride?
methyldopate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.